When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Last reviewed: 17 Mar 2025
Last updated: 25 Apr 2024

Summary

Definition

History and exam

Key diagnostic factors

  • presence of risk factors
  • abrupt onset of high fever
  • flu-like illness
  • severe headache
  • cough
  • inspiratory crackles, rhonchi, or wheezing
  • hepatomegaly

Other diagnostic factors

  • exanthemas
  • pleuritic chest pain
  • seizures
  • coma
  • chronic fatigue
  • signs of endocarditis or vascular infection (persistent focalised infection)
  • other signs of persistent focalised infection
  • other signs of acute infection

Risk factors

  • exposure to infected animals
  • occupational exposure
  • travel or residency in endemic areas
  • male sex
  • age 30 to 70 years
  • immunosuppression
  • pre-existing cardiac disease
  • pre-existing vasculopathy
  • pregnancy

Diagnostic investigations

1st investigations to order

  • indirect immunofluorescence assay (IFA)
  • polymerase chain reaction (PCR)
  • FBC
  • CRP
  • LFTs
  • activated partial thromboplastin time (aPTT)
  • IgG anticardiolipin (aCL) antibodies

Investigations to consider

  • cerebrospinal fluid cell count and differential
  • cerebrospinal fluid protein
  • cerebrospinal fluid glucose
  • CXR
  • transthoracic echocardiography (TTE)
  • transoesophageal echocardiography (TOE)
  • liver ultrasound
  • abdominal CT scan or ultrasound
  • chest CT
  • brain CT
  • 18F-fluorodeoxyglucose (FDG) PET/CT imaging
  • lymph node biopsy
  • immunohistochemistry
  • fluorescence in situ hybridisation (FISH)

Treatment algorithm

Contributors

Authors

Stephen Gluckman, MD

Professor of Medicine

Medical Director, Penn Global Medicine

Hospital of the University of Pennsylvania

Penn International Medicine and Immunization Clinic; Penn Center for Primary Care

Philadelphia

PA

Disclosures

SG declares that he has no competing interests.

Acknowledgements

Professor Stephen Gluckman would like to gratefully acknowledge Dr Joshua Hartzell, Dr Matthieu Million, Professor Didier Raoult, and Dr Nilmarie Guzman, previous contributors to this topic.

Disclosures

MM and DR are authors of several references cited in this topic. JH and NG declare that they have no competing interests.

Peer reviewers

Jennifer McQuiston, DVM, MS, DACVPM

Epidemiology Team

Rickettsial Zoonoses Branch

National Center for Zoonotic Vectorborne and Enteric Diseases

Centers for Disease Control and Prevention

Atlanta

GA

Disclosures

JM declares that she has no competing interests.

Dimitrios Chatzidimitriou, MD, PhD

Clinical Microbiologist

National Influenza Center

Second Department of Microbiology

Aristotle University of Thessaloniki Medical School

Thessaloniki

Greece

Disclosures

DC declares that he has no competing interests.

Use of this content is subject to our disclaimer